Gallery
- Karnataka rain fury: Photos of flooded streets, uprooted treesCannes 2022: Deepika Padukone stuns at the French Riviera in Sabyasachi outfitRanbir Kapoor And Alia Bhatt's Wedding Pics - Sealed With A KissOscars 2022: Every Academy Award WinnerShane Warne (1969-2022): Australian cricket legend's life in picturesPhotos: What Russia's invasion of Ukraine looks like on the groundLata Mangeshkar (1929-2022): A pictorial tribute to the 'Nightingale of India'PM Modi unveils 216-feet tall Statue of Equality in Hyderabad (PHOTOS)Wedding pics: Mouni Roy marries Suraj Nambiar in South Indian ceremony73rd Republic Day Parade 2022 - In Pictures
Olympic bronze medallist Bajrang Punia has been provisionally suspended by the National An
- Laureus Award 2024 : Novak Djokovic, Aitana Bonmati win top honours at Laureus Sports Awards
- Asian Games medallist Jyothi Yarraji to train in Spain ahead of Paris Olympics
- Lione Messi said Retirement not on my mind
- Indian Wells: Alcaraz, Swiatek win titles
- African footballer chased and thrashed away in Kerala; reports
Nepal approves Chinese Covid vaccine Last Updated : 18 Feb 2021 01:22:20 PM IST Nepal government on Wednesday granted emergency use approval to a Covid-19 vaccine developed by the Beijing Institute of Biological Products Co Ltd. (BIBP) in China under Sinopharm.
Nepal has already granted approval for AstraZeneca's Covishield vaccine on January 15.Department of Drug Administration of Nepal on Wednesday decided to issue a conditional permission for emergency use authorisation to the vaccine, according to the administration press statement.By providing the emergency use authorisation, the department paves the way to bring Shinopharm's vaccine in Nepal. China has decided to provide 500,000 doses of BBIBP-CorV vaccine, developed by Sinopharm, under grant assistance.However, Nepal has received one million doses of Covid vaccine from India on third week of January while decided to procure another two million vaccine from Serum Institute of India on a subsidy rate.Sinopharm had applied for emergency use authorisation for its vaccine on January 13 with the department.Of the three applications—two from India and one from China's Shinopharm—the department on January 15 had given emergency use authorisation to only Covishield vaccine developed by the University of Oxford and pharmaceutical giant AstraZeneca, which is produced in India by the Serum Institute of India. The department had demanded necessary documents with Sinopharm and Bharat Biotech.On 30 December 2020, Sinopharm announced the vaccine's efficacy was 79.34 per cent, which was lower than the 86 per cent announced by the United Arab Emirates on December 9. The UAE had based its results on an interim analysis of Phase III trials conducted from July.IANS Kathmandu For Latest Updates Please-
Join us on
Follow us on
172.31.16.186